ONTARGET Trial
New England Journal of Medicine (2008)
Non-inferior to ramipril for MACE with significantly fewer cough events.
Telmisartan
Oral tablet (20mg, 40mg, 80mg), Combination tablet (40mg + 12.5mg HCTZ)Available in all 50 statesMarketing purposes only. Actual medications, if prescribed, are dispensed by a licensed pharmacy.
heart
Long-acting ARB with the longest half-life (~24 hours) of any ARB, providing superior 24-hour BP coverage. Unique partial PPAR-gamma agonist activity confers metabolic benefits beyond BP reduction.
Superior 24-hour BP coverage
PPAR-gamma partial agonism improves insulin sensitivity
Renoprotective
Non-inferior to ramipril for CV outcomes with better tolerability
No commitment · HSA/FSA eligibleNo commitment · HSA/FSA eligible
How it works
Blocks angiotensin II at AT1 receptors. Additionally acts as partial PPAR-gamma agonist (via benzimidazole structure), improving insulin sensitivity and lipid metabolism.
Every Marek client receives this baseline panel before a provider review. Your provider may add additional biomarkers based on your health history, symptoms, and goals, pulling from 1,000+ available markers. See more biomarkers →
Sex hormones
Adrenals & neurosteroids
Growth hormone / IGF-1
Thyroid hormones
Cardiovascular health
Insulin sensitivity
Liver & pancreas
Kidney function
Comprehensive Metabolic Panel (CMP)
Prostate health
Vitamins & minerals
Iron status
Complete Blood Count (CBC)
Clinical evidence
New England Journal of Medicine (2008)
Non-inferior to ramipril for MACE with significantly fewer cough events.
Safety profile
FAQ
Long-acting ARB with the longest half-life (~24 hours) of any ARB, providing superior 24-hour BP coverage. Unique partial PPAR-gamma agonist activity confers metabolic benefits beyond BP reduction.
Treatments are dependent on licensed clinical prescription. Client costs vary based on individual labs and panel in treatments and services.